Latest G protein-coupled receptor Stories
LONDON and BOSTON, November 20, 2014 /PRNewswire/ -- Project to develop first-in-class selective and orally available GLP-1 receptor antagonist for treating severe
LOS ANGELES and SHANGHAI, Oct. 28.
LONDON and BOSTON, September 16, 2014 /PRNewswire/ -- Heptares Therapeutics notes that its Chief Scientific Officer, Fiona Marshall, will give a presentation entitled "Structure-based
Experienced Financial and Operational Leader to Support Global Development of Novel Monoclonal Antibody Therapeutics to GPCRs LA JOLLA, Calif. and SHANGHAI, Sept.
LONDON and BOSTON, June 30, 2014 /PRNewswire/ -- Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, is delighted to announce
LONDON and BOSTON, June 24, 2014 /PRNewswire/ -- Heptares Therapeutics, the leading GPCR structure-guided drug discovery and development company, announces that its President,
A team of scientists from Duke Medicine, the University of Michigan and Stanford University has determined the underlying architecture of a cellular signaling complex involved in the body's response to stimuli such as light and pain.
LA JOLLA, Calif.
- Sleep; the state or condition of being asleep.
- The state or condition of numbness of a part due to pressure on a nerve: as, the obdormition of a limb.